title: Immunosuppressive therapy is valuable in aggressive multiple sclerosis.
authors.affiliation: Multiple Sclerosis Research Unit, The Royal Melbourne Hospital, Melbourne, Australia.
authors.forename: T J
authors.initials: TJ
authors.lastname: Kilpatrick
authors.forename: H
authors.initials: H
authors.lastname: Butzkueven
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008942:Mitoxantrone / Q000627:therapeutic use; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D005719:gamma-Globulins / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D003520:Cyclophosphamide; D008942:Mitoxantrone